|
Feb 01, 2012
|
AspenBio Sets 2012 AppyScore Anticipated Milestones; Sees Pivotal Clinical Trial for Appendicitis Test Beginning Mid-2012
|
|
Dec 30, 2011
|
AspenBio Closes $1.6 Million Registered Direct Offering
|
|
Dec 27, 2011
|
AspenBio Announces Registered Direct Offering of Approximately $1.6 Million
|
|
Nov 28, 2011
|
AspenBio Reports Data From AppyScore Pilot Study and Planned Product Pathway
|
|
Nov 21, 2011
|
AspenBio Pharma to Report Results From Recently Completed AppyScore(TM) Pilot Study, Product Profile and Upcoming Milestones
|
|
Oct 31, 2011
|
AspenBio Awarded ISO 13485 Certification
|
|
Oct 19, 2011
|
AspenBio Reports Interim Data From AppyScore Pilot Study and Outlook for Regulatory Pathway
|
|
Oct 17, 2011
|
AspenBio Pharma to Hold Investor Update Call on Wednesday, October 19, 2011 at 4:30 p.m. ET
|
|
Jul 22, 2011
|
AspenBio to Present at Canaccord Genuity Annual Growth Conference on August 9, 2011
|
|
Jul 21, 2011
|
AspenBio to Maintain NASDAQ Listing With Reverse Split of Common Stock
|
|
Jul 19, 2011
|
AspenBio’s AppyScore™ Pre-Pivotal Trial Advances With Patient Enrollment Ongoing at Seven Hospitals
|
|
Jun 10, 2011
|
Liolios Group to Lead Investor Relations Program for AspenBio Pharma
|
|
Feb 24, 2011
|
AspenBio Granted 180-Day Extension by NASDAQ to Regain Compliance With Bid Price Requirement
|
|
Jan 18, 2011
|
AspenBio Adds Erik Miller as Vice President, Marketing and Business Development
|
|
Jan 01, 2011
|
AspenBio AppyScore™ Update - Shareholder Letter Jan. 2011
|
|
Nov 04, 2010
|
AspenBio Receives Research Award From Federal Government on AppyScore(TM)
|
|
Oct 26, 2010
|
AspenBio Advances AppyScore(TM) Cassette-Based Test and Adds Regulatory and Sales and Marketing Expertise
|
|
Oct 12, 2010
|
AspenBio Streamlines Its Governance Structure
|
|
Aug 06, 2010
|
AspenBio Pharma to Present at the Canaccord Genuity 30th Annual Growth Conference
|
|
Jul 19, 2010
|
AspenBio Pharma Reports AppyScore(TM) ELISA-Based Pivotal Trial Results and Outlines Plans for AppyScore Cassette-Based Test
|
|
Jun 07, 2010
|
AspenBio Pharma Updates on AppyScore(TM) FDA 510(k) Filing and Data Analysis
|
|
Apr 30, 2010
|
AspenBio Pharma Announces Registered Direct Common Stock and Warrant Offering of $10.0 Million
|
|
Mar 25, 2010
|
AspenBio Continues to Strengthen Leadership Adding Steve Lundy as CEO
|
|
Mar 23, 2010
|
AspenBio Completes Patient Enrollment of AppyScore Clinical Trial to Support FDA 510(k) Submission
|
|
Mar 10, 2010
|
AspenBio Pharma Enters Into Development and Supply Agreement for AppyScore(TM) Cassette With BBInternational
|
|
Feb 09, 2010
|
AspenBio Pharma Reports on AppyScore(TM) Supplemental Clinical Trial Interim Analysis and Provides Guidance on FDA 510(k) Filing
|
|
Jan 28, 2010
|
AspenBio Pharma Enters Into Development and Supply Agreement for AppyScore(TM) Reader
|
|
Dec 29, 2009
|
AspenBio Pharma Reports Progress on the Supplemental Clinical Trial, Work to Improve the Clinical Utility of AppyScore(TM) and Scheduled Meeting With FDA
|
|
Nov 13, 2009
|
AspenBio to Present at the Lazard Capital Market 6th Annual Healthcare Conference
|
|
Oct 14, 2009
|
AspenBio Pharma Fills Key Animal Health and Quality Leadership Positions
|
|
Oct 14, 2009
|
AspenBio Pharma Announces Closing of Public Offering of 5,155,000 Common Shares
|
|
Oct 07, 2009
|
AspenBio Pharma Announces Public Offering of 4,482,609 Common Shares
|
|
Sep 16, 2009
|
AspenBio Adds Greg Bennett as Vice President of Product Development and Manufacturing
|
|
Sep 03, 2009
|
AspenBio Pharma to Present at the Rodman & Renshaw Annual Global Investment Conference
|
|
Sep 03, 2009
|
AspenBio Pharma to Present at the Annual Baird Healthcare Conference
|
|
Aug 21, 2009
|
AspenBio Pharma 510(k) Filing for AppyScore Advances in FDA Review With Request for Additional Information
|
|
Jul 30, 2009
|
AspenBio Pharma to Present at the Canaccord Adams 29th Annual Global Growth Conference
|
|
Jun 30, 2009
|
AspenBio Pharma Files 510(k) Notification With FDA for AppyScore(TM) Test
|
|
Jun 08, 2009
|
AspenBio Pharma Forms Medical Advisory Board for AppyScore(TM), the World's First Blood Test to Aid in the Diagnosis of Appendicitis
|
|
May 18, 2009
|
AspenBio Pharma AppyScore(TM) Diagnostic Blood Marker Presented at 2009 Annual Meeting of Society for Academic Emergency Medicine
|
|
Mar 12, 2009
|
AspenBio Pharma to Proceed With FDA 510(k) Application for AppyScore(TM)
|
|
Mar 12, 2009
|
AspenBio Pharma to Host Investor Update Call Today at 4:30 PM ET
|
|
Feb 11, 2009
|
AspenBio Announces Management Team Changes
|
|
Feb 11, 2009
|
AspenBio Appoints Robert Caspari, M.D. as Chief Operating Officer and Chief Medical Officer
|
|
Feb 06, 2009
|
AspenBio Pharma to Present at the ROTH Capital Partners 21st Annual OC Growth Stock Conference
|
|
Jan 20, 2009
|
AspenBio Expands Leadership With Addition of Daryl J. Faulkner as Executive Chairman
|
|
Jan 20, 2009
|
AspenBio Pharma Reports Preliminary Results of AppyScore(TM) Clinical Study
|
|
Dec 22, 2008
|
AspenBio Expands Board With Addition of John H. Landon
|
|
Dec 17, 2008
|
AspenBio Receives Patent Office Notice of Allowance for Appendicitis Diagnostic Methods
|
|
Dec 10, 2008
|
AspenBio Completes Clinical Study Patient Enrollment for AppyScore, World's First Blood-Based Diagnostic Test for Human Appendicitis
|
|
Nov 18, 2008
|
AspenBio Pharma Reports on FDA 510(k) Clinical Trial Progress for AppyScore, World's First Blood-Based Diagnostic Test for Human Appendicitis
|
|
Nov 05, 2008
|
AspenBio Pharma to Present at the Lazard Capital Markets 5th Annual Healthcare Conference in New York City on November 18
|
|
Oct 22, 2008
|
AspenBio Pharma Reports on FDA 510(k) Clinical Trial Progress for AppyScore, World's First Blood-Based Diagnostic Test for Human Appendicitis
|
|
Sep 04, 2008
|
Patient Enrollment for AspenBio Pharma's FDA 510(k) Clinical Trial for AppyScore(TM), World's First Appendicitis Blood Test, Nearing Halfway Point
|
|
Aug 11, 2008
|
AspenBio Pharma to Present at the Noble Financial Equity Conference
|
|
Aug 05, 2008
|
AspenBio Pharma to Present at the 28th Annual Canaccord Adams Global Growth Conference
|
|
Jul 08, 2008
|
Michael R. Merson Joins AspenBio Pharma's Board of Directors
|
|
Jun 30, 2008
|
AspenBio Pharma Joins Russell Microcap Index
|
|
Jun 26, 2008
|
AspenBio Pharma Commences FDA Clinical Trial for AppyScore(TM) Appendicitis Blood Test
|
|
May 12, 2008
|
AspenBio Pharma to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
|
|
Apr 25, 2008
|
AspenBio Pharma Initiates Stock Buyback Plan
|
|
Apr 23, 2008
|
AspenBio Pharma Advances AppyScore Towards Clinical Trials With Improved Specificity for Detecting Human Appendicitis
|
|
Apr 07, 2008
|
AspenBio Pharma Enters Worldwide License Agreement for Bovine Reproduction Drugs
|
|
Mar 31, 2008
|
AspenBio Pharma Appoints Dr. Mark Ratain to Board of Directors
|